1
|
González-Salazar F, Garza-González JN, Hernandez-Luna CE, Mata-Cárdenas BD, Carranza-Rosales P, Castro-Garza JE, Hernández-García ME, Vargas-Villarreal J. Sphingomyelinase activity of Trichomonas vaginalis extract and subfractions. BIOMED RESEARCH INTERNATIONAL 2013; 2013:679365. [PMID: 24024206 PMCID: PMC3760288 DOI: 10.1155/2013/679365] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/29/2013] [Accepted: 07/10/2013] [Indexed: 11/18/2022]
Abstract
Trichomoniasis is one of the most common acute sexually transmitted curable diseases, and it is disseminated worldwide generating more than 170 million cases annually. Trichomonas vaginalis is the parasite that causes trichomoniasis and has the ability to destroy cell monolayers of the vaginal mucosa in vitro. Sphingomyelinases (SMase) are enzymes that catalyze the hydrolysis of sphingomyelin into ceramide and phosphorylcholine. Ceramide appears to be a second messenger lipid in programmed apoptosis, cell differentiation, and cell proliferation. Sphingomyelinase is probably a major source of ceramide in cells. Signal transduction mediated by ceramide leads cells to produce cytokine induced apoptosis during several inflammatory responses. SMase are also relevant toxins in several microorganisms. The main objective of this research is to identify SMase activity of T. vaginalis in the total extract (TE), P30, and S30 subfractions from brooked trophozoites. It was found that these fractions of T. vaginalis have SMase activity, which comes principally from P30 subfraction and was mainly type C. Enzymatic activity of SMase increased linearly with time and is pH dependent with two peaks by pH 5.5 and pH 7.5. The addition of manganese to the reaction mixture increased the SMase activity by 1.97.
Collapse
Affiliation(s)
- Francisco González-Salazar
- División de Biología Celular y Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Administración de Correo No. 4, 2 de abril 501 Colonia Independencia, 64720 Monterrey, NL, Mexico
- Departamento de Ciencias Básicas, División de Ciencias de la Salud, Universidad de Monterrey, Avenida Morones Prieto 4500 Pte, 66238 San Pedro Garza García, NL, Mexico
| | - Jesús N. Garza-González
- División de Biología Celular y Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Administración de Correo No. 4, 2 de abril 501 Colonia Independencia, 64720 Monterrey, NL, Mexico
- Departamento de Biología Celular y Genética, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, 66451 San Nicolás de los Garza, NL, Mexico
| | - Carlos E. Hernandez-Luna
- Laboratorio de Enzimología, Facultad de Ciencias Biológicas, UANL, San Nicolás de los Garza, NL, Mexico
| | - Benito David Mata-Cárdenas
- Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Avenida Manuel L Barragán S/N, San Nicolás de los Garza, NL, Mexico
| | - Pilar Carranza-Rosales
- División de Biología Celular y Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Administración de Correo No. 4, 2 de abril 501 Colonia Independencia, 64720 Monterrey, NL, Mexico
| | - Jorge Enrique Castro-Garza
- División de Biología Celular y Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Administración de Correo No. 4, 2 de abril 501 Colonia Independencia, 64720 Monterrey, NL, Mexico
| | - Magda Elizabeth Hernández-García
- División de Biología Celular y Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Administración de Correo No. 4, 2 de abril 501 Colonia Independencia, 64720 Monterrey, NL, Mexico
| | - Javier Vargas-Villarreal
- División de Biología Celular y Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Administración de Correo No. 4, 2 de abril 501 Colonia Independencia, 64720 Monterrey, NL, Mexico
| |
Collapse
|
2
|
Dhananjaya BL, D'Souza CJM. The pharmacological role of phosphatases (acid and alkaline phosphomonoesterases) in snake venoms related to release of purines - a multitoxin. Basic Clin Pharmacol Toxicol 2010; 108:79-83. [PMID: 21156030 DOI: 10.1111/j.1742-7843.2010.00630.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Snake venom components, acting in concert in the prey, cause their immobilization and initiate digestion. To achieve this, several hydrolytic enzymes of snake venom have evolved to interfere in various physiological processes, which are well defined. However, hydrolytic enzymes such as phosphatases (acid and alkaline phosphomonoesterases) are less studied and their pharmacological role in venoms is not clearly defined. Also, they show overlapping substrate specificities and have other common biochemical properties causing uncertainty about their identity in venoms. The near-ubiquitous distribution of these enzymes in venoms, suggests a significant role for these enzymes in envenomation. It appears that these enzymes may play a central role in liberating purines (mainly adenosine) - a multitoxin and through the action of purines help in prey immobilization. However, apart from this, these enzymes could also possess other pharmacological activities as venom enzymes have been evolved to interfere in diverse physiological processes. This has not been verified by pharmacological studies using purified enzymes. Further research is needed to biologically characterize these enzymes in snake venoms, such that their role in venom is clearly established.
Collapse
|
3
|
Rael ED, Rivas JZ, Chen T, Maddux N, Huizar E, Lieb CS. Differences in fibrinolysis and complement inactivation by venom from different northern blacktailed rattlesnakes (Crotalus molossus molossus). Toxicon 1997; 35:505-13. [PMID: 9133705 DOI: 10.1016/s0041-0101(96)00139-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Venom from 72 different Crotalus molossus molossus rattlesnakes was examined for fibrinolysis and for their ability to inactivate human complement. The fibrinolytic activity of the venoms was variable, but smaller (younger) snakes had less fibrinolytic activity than larger (older) snakes. Major differences between the venoms was detected by isoelectric focusing, and reflected in the number and pI of the proteins with fibrinolytic activity. Of the 72 venoms tested, ten had no effect and three had low activity on complement. The rest of the venoms strongly inactivated complement. The snakes with no activity on complement measured 55 cm or less in length, except for one snake which measured 53 cm and completely inactivated complement. Two larger snakes (76 and 84 cm) had a reduced complement-inactivating activity. Some venoms strongly hydrolyzed C2, whereas others had mild or no effect on this complement component. The attack on C3 was variable: some had no effect on C3, while other venoms produced a 125,000 mol. wt protein, which was recognized by antibodies to C3. Only mild hydrolysis of C4 was evident in serum treated with some venoms. No relationship was evident between the venom properties of this species and geographical distribution. Venom variability is an important clinical reality, and is an important consideration when attempting to isolate proteases from this snake species for further study.
Collapse
Affiliation(s)
- E D Rael
- Department of Biological Sciences, University of Texas at El Paso 79968-0519, USA
| | | | | | | | | | | |
Collapse
|